MedPath
HSA Approval

CANCIDAS POWDER FOR INJECTION 70 mg/vial

SIN11763P

CANCIDAS POWDER FOR INJECTION 70 mg/vial

CANCIDAS POWDER FOR INJECTION 70 mg/vial

January 10, 2002

MSD PHARMA (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMSD PHARMA (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

J02AX04

caspofungin

Manufacturer Information

MSD PHARMA (SINGAPORE) PTE. LTD.

FAREVA Mirabel (bulk production/primary & secondary packaging)

Active Ingredients

CASPOFUNGIN ACETATE EQV CASPOFUNGIN

70 mg/vial

Caspofungin

Documents

Package Inserts

Cancidas PI.pdf

Approved: August 18, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CANCIDAS POWDER FOR INJECTION 70 mg/vial - HSA Approval | MedPath